Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Aug 2026 for Caris Life Sciences, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
T. Danny Phillips: trading record in brief
T. Danny Phillips discloses dealings in Caris Life Sciences, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 11 September 2025 and the latest from 14 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 14 August 2026 came the latest disclosure, a share grant in Caris Life Sciences, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to T. Danny Phillips
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
13,192 shares0Common StockSEC:0001239690-26-000005:0
3,739 shares@ US$20.0623.4% of flowCommon StockSEC:0001239690-26-000002:0
100,000 shares@ US$2.44100.0% of flowCommon StockSEC:0001239690-25-000008:0
3 of 3 declarations
